ECT produces first MXene on Texas reactor as defence platform advances
Environmental Clean Technologies has produced its first MXene on a US Flash Joule Heating reactor, marking a technical step in its defence materials strategy. The harder work now is proving repeatability, performance and customer qualification while building a separate PFAS pilot.
- First MXene produced on Metallium’s Texas reactor platform
- Xenica acquisition remains subject to outstanding conditions
- A$10.6 million placement lifted cash to A$10.2 million
- Defence sublicence provides market access but no customer contract
- PFAS granular activated carbon pilot targeted for early 2027
Add us as a preferred source on Google
First MXene production moves ECT beyond the licence stage
Environmental Clean Technologies Limited (ASX:ECT) has produced its first MXene on a Flash Joule Heating reactor in Texas, giving the company a physical manufacturing result to build around as it pursues defence applications. The initial runs were completed after the September quarter on Metallium Ltd’s commissioned reactor platform at Gator Point.
Independent X-ray diffraction analysis found changes in interlayer spacing consistent with the formation of chlorine-terminated MXene. The result remains preliminary: ECT says the programme must now demonstrate repeatable production, improve conversion and yield, and validate application-specific performance before samples can move into customer qualification. The update extends the company’s earlier two-run MXene production, which had confirmed formation but left scale-up and qualification unresolved.
Xenica acquisition creates a conditional defence pathway
The manufacturing effort is tied to ECT’s proposed acquisition of Xenica Materials, whose US subsidiary holds an exclusive Rice University licence covering Flash Joule Heating production of MXenes and two-dimensional amorphous carbon. Shareholders approved the issue of 60 million consideration shares on 22 October, but completion still depends on the remaining conditions precedent.
Xenica also holds a sublicence from MXene Inc. to produce, use and sell MXenes for military and defence-related end uses. ECT has identified electromagnetic interference shielding, radar absorption, signature management and advanced coatings as initial targets. That route was outlined in the company’s defence MXene sublicence, but the sublicence is not a customer contract and does not establish future revenue.
US reactor access limits upfront infrastructure spending
ECT has signed a 12-month research and engineering agreement with Metallium and Flash Metals USA, giving it access to the Gator Point reactor and engineering capability without building equivalent infrastructure itself. The arrangement carries an upfront payment of US$500,000 and a quarterly service and facility fee of US$225,000. ECT retains ownership of MXene produced under the agreement, while reactor improvements remain with Metallium.
The company says it is targeting output of approximately 1 kilogram per day once the process is optimised. That is a target rather than an achieved production rate, and the near-term test is whether multiple runs can produce material to consistent, defence-relevant specifications. ECT’s capital-light approach may reduce the initial infrastructure burden, but it leaves the company dependent on partner capacity and still facing the technical cost of qualification.
Placement funds two commercialisation programmes
ECT ended the quarter with approximately A$10.2 million in cash after raising A$10.6 million before costs through the first tranche of a placement at A$0.12 per share. The company recorded net operating cash outflows of A$1.47 million for the quarter, up from A$883,000 in the June quarter, as it accelerated MXene optimisation, independent testing, PFAS pilot work and transaction costs.
The funding was announced alongside the A$10.6 million placement, with a further A$1.4 million tranche approved by shareholders after quarter end. ECT says the proceeds are directed to defined technical and commercial milestones, although it also warns that further capital may be required for commercial-scale deployment.
PFAS pilot targets early 2027 field evidence
ECT is pursuing a second use of its Flash Joule Heating platform through its Rapid Electrothermal Mineralisation process, designed to destroy PFAS captured on granular activated carbon. The company has completed the concept design for a first pilot unit and is preparing safety assessment, fabrication and integration work ahead of initial flash trials targeted for early 2027.
ECT cites laboratory-scale results showing more than 99.9% PFAS removal on GAC and ion-exchange resins, with 96% to 99.9% of fluorine accounted for as inorganic fluoride. Those results have not yet been demonstrated on the planned pilot unit, which is intended to generate the performance data needed for larger systems, licensing and original equipment manufacturer discussions.
Bottom Line?
ECT now has a preliminary product result, US reactor access and funding, but the investment case turns on repeatable MXene output, independent performance data and evidence that either platform can progress beyond pilot economics.
Questions in the middle?
- Can ECT reproduce MXene consistently at Gator Point and approach its stated target of approximately 1 kilogram per day?
- Will independent testing demonstrate defence-relevant performance strong enough to begin meaningful customer qualification?
- Can the PFAS GAC pilot validate laboratory results without pushing the company into another material funding requirement?
Sources
1-
Quarterly Activities/Appendix 4C Cash Flow Report (opens in a new tab)Verified source. Environmental Clean Technologies Limited · 30 Oct 2026